Basket cover image
15 handpicked stocks

Weaponized Convenience

These companies have revolutionized our expectations by making convenience a necessity, not a luxury. Our analysts have selected high-performing businesses that create such frictionless experiences, consumers now can't imagine life without them.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juin 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

AMZN

Amazon.com Inc.

AMZN

Current price

$228.01

As the pioneer of one-click ordering and same-day delivery, its entire retail ecosystem is built on removing friction from shopping.

UBER

Uber Technologies, Inc.

UBER

Current price

$95.32

Its platform offers on-demand transportation and food delivery, making travel and dining exceptionally convenient.

NFLX

Netflix, Inc.

NFLX

Current price

$1,214.15

It disrupted traditional media by providing a vast library of on-demand content, eliminating the friction of broadcast schedules.

About This Group of Stocks

1

Our Expert Thinking

These companies have mastered the art of eliminating friction from everyday tasks. They've created powerful business models by making their services so easy to use – from one-click ordering to instant delivery – that they've become deeply embedded in consumer habits, creating strong barriers against competitors.

2

What You Need to Know

This collection features market leaders who've built ecosystems consumers find indispensable. These companies benefit from network effects and strong customer loyalty, allowing them to maintain competitive advantages. As consumer expectations for immediacy increase, these businesses are positioned for continued growth.

3

Why These Stocks

We've selected dominant platforms across e-commerce, delivery, digital payments, and streaming media that have fundamentally changed how people shop, travel, eat, and entertain themselves. Each company has successfully created a frictionless experience that consumers return to repeatedly.

Group Performance Snapshot

14 of 14

Stocks Rated Buy by Analysts

14 of 14 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🔄

Habit-Forming Services

These companies don't just have customers – they create daily habits. Once consumers experience their frictionless services, they rarely go back to traditional alternatives.

🚀

The Convenience Premium

Companies that save us time command pricing power. As our lives get busier, consumers increasingly pay more for services that deliver convenience and immediacy.

🌐

Global Adoption Wave

The demand for convenience is universal and growing. These companies are riding a worldwide shift in consumer expectations that shows no signs of slowing down.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.